【摘要】：目的:探討酚妥拉明聯(lián)合垂體后葉素治療肺結(jié)核頑固性咯血的臨床療效。方法:選取我院2013年10月至2016年10月收治的84例肺結(jié)核頑固性咯血患者為研究對(duì)象,將所有患者根據(jù)入院順序分為對(duì)照組和研究組,每組42例,對(duì)照組患者單用垂體后葉素靜脈滴注,研究組在對(duì)照組的基礎(chǔ)上聯(lián)合酚妥拉明靜脈滴注,對(duì)比兩組患者的治療效果及不良反應(yīng)發(fā)生情況。結(jié)果:研究組咯血停止時(shí)間為(1.51±0.48)d,治療總有效率為92.86%(39/42),不良反應(yīng)發(fā)生率為7.14%(3/42),對(duì)照組咯血停止時(shí)間為(3.17±0.56)d,治療總有效率為76.19%(32/42),不良反應(yīng)發(fā)生率為28.57%(12/42),兩組比較差異性顯著(P0.05)。結(jié)論:酚妥拉明聯(lián)合垂體后葉素能有效的提高肺結(jié)核頑固性咯血的臨床療效顯著,且不良反應(yīng)少,具有一定的臨床應(yīng)用價(jià)值。
[Abstract]:Objective: to investigate the clinical effect of phentolamine combined with Pituitrin in the treatment of refractory hemoptysis of pulmonary tuberculosis. Methods: from October 2013 to October 2016, 84 patients with refractory hemoptysis of pulmonary tuberculosis were selected and divided into control group (n = 42) and study group (n = 42) according to the order of admission. The patients in the control group were treated with Pituitrin alone, and the patients in the study group were treated with phentolamine intravenous drip on the basis of the control group. The therapeutic effects and adverse reactions of the two groups were compared. Results: the stopping time of hemoptysis was (1.51 鹵0.48) days in the study group, the total effective rate was 92.86% (39 鈮，

本文編號(hào)：2491670